Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 6/2012

01-06-2012 | Stanford Multidisciplinary Seminars

Abdominal Mass, Anemia, Diabetes Mellitus, and Necrolytic Migratory Erythema

Authors: Motaz Qadan, Brendan Visser, Jinah Kim, Reetesh Pai, George Triadafilopoulos

Published in: Digestive Diseases and Sciences | Issue 6/2012

Login to get access

Excerpt

A 47-year-old Hispanic man presented to an outside hospital in March 2011 for evaluation of nausea, vomiting, fatigue, intermittent diarrhea, and weight-loss. …
Literature
1.
Becker SW, Kahn D, Rothman S. Cutaneous manifestations of internal malignant tumors. Arch Dermatol Syph. 1942;45:1069.CrossRef
2.
McGavran MH, Unger RH, Recant L, Polk HC, Kilo C, Levin ME. A glucagon-secreting alpha-cell carcinoma of the pancreas. N Engl J Med. 1966;274:1408–1413.PubMedCrossRef
3.
4.
Stacpoole PW. The glucagonoma syndrome: clinical features, diagnosis, and treatment. Endocr Rev. 1981;2:347–361.PubMedCrossRef
5.
Guillausseau PJ, Guillausseau-Scholer C. Glucagonomas: Clinical Presentation, Diagnosis, and Advances in Management. Basel: Karger; 1995.
6.
Yao JC, Eisner MP, Leary C, et al. Population-based study of islet cell carcinoma. Ann Surg Oncol. 2007;14:3492–3500.PubMedCrossRef
7.
Kindmark H, Sundin A, Granberg D, et al. Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years. Med Oncol. 2007;24:330–337.PubMedCrossRef
8.
Norton JA, Barie PS, Bollinger RR, et al. Surgery: Basic Science and Clinical Evidence. 2nd edn. New York: Springer; 2008.
9.
Wermers RA, Fatourechi V, Wynne AG, Kvols LK, Lloyd RV. The glucagonoma syndrome. Clinical and pathologic features in 21 patients. Medicine (Baltimore). 1996;75:53–63.CrossRef
10.
Rosch T, Lightdale CJ, Botet JF, et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med. 1992;326:1721–1726.PubMedCrossRef
11.
Norton JA, Harris EJ, Chen Y, et al. Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection. Arch Surg. 2011;146:724–732.PubMedCrossRef
12.
Maton PN. Use of octreotide acetate for control of symptoms in patients with islet cell tumors. World J Surg. 1993;17:504–510.PubMedCrossRef
13.
Wilkinson DS. Necrolytic migratory erythema with carcinoma of the pancreas. Trans St Johns Hosp Dermatol Soc. 1973;59:244–250.PubMed
14.
van Beek AP, de Haas ER, van Vloten WA, Lips CJ, Roijers JF, Canninga-van Dijk MR. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review. Eur J Endocrinol. 2004;151:531–537.PubMedCrossRef
15.
Norton JA, Kahn CR, Schiebinger R, Gorschboth C, Brennan MF. Amino acid deficiency and the skin rash associated with glucagonoma. Ann Intern Med. 1979;91:213–215.PubMed
Metadata
Title
Abdominal Mass, Anemia, Diabetes Mellitus, and Necrolytic Migratory Erythema
Authors
Motaz Qadan
Brendan Visser
Jinah Kim
Reetesh Pai
George Triadafilopoulos
Publication date
01-06-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1967-5

Other articles of this Issue 6/2012

Digestive Diseases and Sciences 6/2012 Go to the issue

Original Article

The Effects of 5-HT4 Receptor Agonist, Mosapride Citrate, on Visceral Hypersensitivity in a Rat Model

Original Article

Impairment of Gastric Nitrergic and NRF2 System in Apolipoprotein E Knockout Mice

Original Article

Down-Regulation of Claudin-3 Is Associated with Proliferative Potential in Early Gastric Cancers

Original Article

A Study on the Efficacy of Rebamipide for Patients with Proton Pump Inhibitor-Refractory Non-Erosive Reflux Disease

Brief Communication

Safety of Capsule Endoscopy Using Human Body Communication in Patients with Cardiac Devices

Original Article

Is Ulcerative Colitis Associated with Survival Among Older Persons with Colorectal Cancer in the US? A Population-Based Case–Control Study
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits